Replies to post #76764 on Value Microcaps Motherboard

[houtheman]

Hi there.

I have to do a more in-depth analysis but here are my thoughts so far - correct me if I am wrong on anything:

1. anti-inflammation drugs a new class, not an NSAID or steroid - and seems not to require FDA approval because it's considered an herbal??
2. I am huge on making decisions based on what sector the company is in. If #1 above is true - then this company warrants more research. I used to work for Pfizer promoting Celebrex and as you know both Celebrex, Vioxx and the entire COX-2 class got slammed after Vioxx was voluntarily withdrawn. I need to learn more about the product but if the target market is anti-inflammation - there is potentially a huge market out there and explosive growth
3. I see news releases about revenue exploding but needs deeper look into. Will try to do that tomorrow.

let me know if #1 above is correct.

[True FL Native]

IAGX filing today
http://www.sec.gov/Archives/edgar/data/839441/000114420407037067/v081113_sb2.htm